Researchers developed PRTS, a deep learning model that infers single-cell spatial transcriptomics from standard H&E-stained tissue images.
Key Details
- 1PRTS stands for Pathology-driven Reconstruction of Transcriptomic States.
- 2It predicts an expression matrix for 1,820 genes at single-cell resolution from H&E images.
- 3The method provides 27x higher resolution than traditional spatial transcriptomics spot technologies.
- 4Validated on mouse brain, human lung cancer, and breast cancer datasets.
- 5PRTS identified 21 cell subtypes and matched key gene expression patterns to ground truth.
- 6Potential applications include diagnostics, cancer subtyping, and drug discovery.
Why It Matters
PRTS could enable cost-effective, scalable spatial transcriptomics directly from routinely collected pathology slides, advancing both research and diagnostics where gene expression mapping was previously prohibitively expensive or impractical.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.